Nalu Bio
↗San Francisco, USA
Nalu Bio is a biotechnology company pioneering a chemistry-based approach to the synthesis of ultra-pure, non-hemp-derived cannabinoids. The company leverages a proprietary AI-driven drug discovery platform to target the endocannabinoid system (ECS), aiming to develop next-generation therapeutics and consumer health products for inflammatory, immune, and metabolic diseases.
By utilizing organic chemistry rather than plant extraction, Nalu Bio produces molecularly identical cannabinoids (such as CBD and THCV) that are free from the contaminants, inconsistency, and regulatory stigma associated with hemp. The company is particularly focused on addressing the 'women's wellness gap' through its brand extension, Meld, which targets sleep, weight management, and mobility.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Cannabinoid synthesis & ECS therapeutics
SIZE & FINANCIALS
Employees:1-50
Revenue:Generating Revenue
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$13.5M
Investors:Intrinsic Capital Partners, Flybridge Capital Partners, Portfolia, Bonaventure Equity, L37 Ventures, Golden Seeds, Sacramento Angels, Brown Angel Group, Axial Venture, Springboard Enterprises
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Small molecule, Synthetic Cannabinoids
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Meld (Wellness Brand)
Key Partnerships:PIPA (AI and biological modeling for bioactive combinations), Global specialty chemical manufacturer (Scale-up agreement)
COMPETITION
Position:Emerging
Competitors:Hyasynth Biologicals, Willow Biosciences, Ginkgo Bioworks, Cronos Group, Lygos
LEADERSHIP
Key Executives:
Caitlyn Krebs - CEO & Co-Founder
Grazia Piizzi, PhD - Chief Scientific Officer
Alex Dorenbaum, MD - Chief Medical Officer
Matthew Roberts, PhD - Chief Technology Officer
Scientific Founders:Caitlyn Krebs, Phyllis Whiteley, PhD
Board Members:Phyllis Whiteley (Chairman), Howard Goodwin (Intrinsic Capital Partners), Dondeena Bradley (Former VP at Mars Wrigley and PepsiCo)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Nalu Bio. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.